Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Epigenetic treatment of synaptic and behavioral deficits in Dyrk1a-mutant mice
    Published on 2026-01-19
    8 months ago
  • Multiple sources of β2*-nicotinic acetylcholine receptor binding are differentially affected during tobacco smoking abstinence as revealed by Independent Component Analysis of [18F]Flubatine PET images
    Published on 2026-01-19
    8 months ago
  • Modulation of accumbens dopamine by MCH neurons during learning and consummatory behavior
    Published on 2026-01-18
    8 months ago
  • Excitation–inhibition homeostasis in Alzheimer’s disease: a selective multiscale review of mechanisms, sex differences, and therapeutic opportunities
    Published on 2026-01-18
    8 months ago
  • Vascular cognitive impairment and dementia: Prevention, treatments, mechanisms and management options for the future
    Published on 2026-01-18
    8 months ago
  • Incentive salience, not psychomotor sensitization or tolerance, drives escalation of cocaine self-administration in heterogeneous stock rats
    Published on 2026-01-16
    8 months ago
  • Oxytocin neurons in the anterior and posterior paraventricular nucleus have distinct behavioral functions and electrophysiological profiles
    Published on 2026-01-16
    8 months ago
« Previous 1 … 32 33 34 35 36 … 143 Next »
Journal of Psychopharmacology
  • Enhancing mindfulness and compassion through an ayahuasca-inspired formulation containing N,N-DMT and harmine: A randomized controlled trial in healthy subjects
    Published on 2025-06-19
    1 year ago
  • Naturalistic use of psychedelics is associated with longitudinal improvements in anxiety and depression during global crisis times
    Published on 2025-06-18
    1 year ago
  • Uncertainty about lithium and suicide: A response to Nassir Ghaemi
    Published on 2025-06-17
    1 year ago
  • Dissecting the pro-neurogenic effects of monoaminergic medications used to treat depression: a systematic review and meta-analysis
    Published on 2025-06-11
    1 year ago
  • A model training curriculum for psychedelic, psycholytic, and entactogen-assisted psychotherapy
    Published on 2025-06-10
    1 year ago
  • Six weeks open-label oral ketamine for patients with treatment-resistant depression, post-traumatic stress disorder, or obsessive-compulsive disorder
    Published on 2025-06-05
    1 year ago
  • Effects of serotonergic psychedelics on synaptogenesis and immediate early genes expression – comparison with ketamine, fluoxetine and lithium
    Published on 2025-05-29
    1 year ago
« Previous 1 … 32 33 34 35 36 … 154 Next »
European Neuropsychopharmacology
  • “Much ado about nothing?” advocating for neuroscientific research in maternal perfectionism and perinatal mental health disorders
    Published on 2025-02-17
    2 years ago
  • On the potential of xanomeline-trospium chloride for schizophrenia and beyond
    Published on 2025-02-17
    2 years ago
  • Whole-brain functional neuroimaging correlates of cognitive flexibility impairments in people with mental disorders: A transdiagnostic coordinate-based meta-analysis
    Published on 2025-02-16
    2 years ago
  • Letter to the editor concerning: “Efficacy, tolerability, and safety of xanomeline-trospium chloride for schizophrenia: A systematic review and meta-analysis”
    Published on 2025-02-16
    2 years ago
  • Methylation profile scores of environmental exposures and risk of relapse after a first episode of schizophrenia
    Published on 2025-02-16
    2 years ago
  • Artificial intelligence in healthcare: Revolution or unfulfilled promise?
    Published on 2025-02-16
    2 years ago
  • Prescription sequences in bipolar disorder – A nationwide Danish register-based study of 19,927 individuals followed for 10 years
    Published on 2025-02-16
    2 years ago
« Previous 1 … 32 33 34 35 36 … 170 Next »

   Pharma Pub